UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
TECH LABORATORIES, INC.
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
(Title of Class of Securities)
878249101
(CUSIP Number)
CRAIG H. EFFRAIN, ESQ.
STURSBERG & VEITH
405 LEXINGTON AVENUE, SUITE 4949, NEW YORK, NY 10174-4902
(212) 922-1177
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
3/24/01
(Date of Event which Requires Filing
of this Statement)
1 of 4
CUSIP No. 13D
878249101
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BERNARD M. CIONGOLI
154366764
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO THIS STATEMENT IS BEING FILED PURSUANT TO A GRANT OF STOCK
OPTIONS, EXERCISABLE WITHIN 60 DAYS, BY TECH LABS TO MR. CIONGOLI.
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 953,334
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 953,334
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
953,334
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.81%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
2 of 4
Schedule 13D
Item 1. Security and Issuer
This statement relates to the Common Stock, $.01 Par Value of Tech
Laboratories, Inc., 955 Belmont Avenue, North Haledon, NJ 07508.
Item 2. Identity and Background
(a) Bernard M. Ciongoli
(b) Tech Laboratories, Inc.
955 Belmont Avenue
North Haledon, NJ 07508
(c) Mr. Ciongoli is the president of Tech Laboratories, Inc.
(d) None
(e) None
(f) USA
Item 3. Source and Amount of Funds or Other Consideration
This Schedule is being filed pursuant to a grant of stock options by the
Company to Mr. Ciongoli which are exercisable within 60 days. Mr. Ciongoli was
granted a non-qualified, non-plan option to purchase up to 139,000 shares of the
Company's common stock on April 24, 2001. Options to purchase 46,334 shares
vested on May 1, 2001 and options to purchase 46,333 shares vest on each of May
1, 2002 and May 1, 2003. The options expire on April 24, 2006.
Item 4. Purpose of Transaction
See Item 3.
Item 5. Interest in Securities of the Issuer
See Items 7 through 13 of the cover page to this Schedule 13D/A. As of the
date of this report Mr. Ciongoli beneficially owned 953,334 shares. Such number
of shares include 433,334 shares of common stock issuable upon exercise of
options that are immediately exercisable. These numbers do not include options
to purchase up to (i) 50,000 shares that vest to Mr. Ciongoli next year granted
under the Company's 1996 Stock Option Plan, (ii) options to purchase up to
74,000 shares that vest over the next two years also granted under the Company's
1996 Stock Option Plan and (iii) options to purchase up to 92,666 shares that
vest over the next two years granted under a non-qualified, non-plan stock
option agreement. To the knowledge of Bernard M. Ciongoli, the Issuer has
4,379,939 shares of common stock, par value $.01 per share outstanding on the
date hereof.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.
None
Item 7. Material to be Filed as Exhibits
None
3 of 4
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: May 4, 2001 /s/ BERNARD M. CIONGOLI
-----------------------------------
Signature
BERNARD M. CIONGOLI
-----------------------------------
Name/Title
4 of 4